[ET Net News Agency, 24 October 2019] Sinopharm Group Co. Ltd. (01099) announced the
results of its subsidiary China National Accord Medicines Corporation Ltd.
Its net profit attributable to shareholders of the listed company was RMB311.31 million
for the nine months ended 30 September 2019, a year-on-year increase of 9.14%. The
earnings per share were RMB0.735.
The operating revenue was RMB13.65 billion, a year-on-year increase of 24.21%. (RC)